|
INTEGRIS Pharma is a fast-growing Greek pharmaceutical company.
|
About us
INTEGRIS Pharma was founded in 2008 as a CNS generics pharma. In 2018, the company successfully relaunched its business model, with a clear mission to cover the unmet therapeutic needs of patients with rare, chronic and life-threatening diseases in Greece and Cyprus, through innovative therapeutics.
Consistently serving this new strategic focus, INTEGRIS Pharma is actively seeking for innovative medicines throughout the world and is committed to ensure direct access for all patients, in the countries the company operates.
|
|
INTEGRIS Pharma is a fast-growing Greek pharmaceutical company.
|
|
|
About us
INTEGRIS Pharma was founded in 2008 as a CNS generics pharma. In 2018, the company successfully relaunched its business model, with a clear mission to cover the unmet therapeutic needs of patients with rare, chronic and life-threatening diseases in Greece and Cyprus, through innovative therapeutics.
Consistently serving this new strategic focus, INTEGRIS Pharma is actively seeking for innovative medicines throughout the world and is committed to ensure direct access for all patients, in the countries the company operates.
|
|
Within the last 5 years, INTEGRIS Pharma has entered into 13 new partnerships with leading, global biopharmaceutical companies and has built an extensive and diverse product portfolio for more than 17 diseases.
The company’s portfolio includes orphan drugs for rare and ultra-rare diseases, innovative pharmaceuticals complemented with hybrid and generic products in the fields of Oncology and Hematology as well as first-in-class medical devices for wound healing.
Recognizing the significant impact of these diseases on the lives of patients, their families, and caregivers, the company is committed to a comprehensive disease management from prevention to diagnosis, extending from product management that meets the highest quality and safety standards, to patient-centric initiatives that aim to address the needs of patients across their journey with the disease.
| Our mission | |
|
and values
Our mission is to address the unmet therapeutic needs of patients with rare, chronic and life-threatening diseases through innovative treatments.
We serve the patients and stand by the healthcare professionals, with integrity, honesty and transparency. We build relationships and partnerships that are based on mutual trust. Not only within our corporate environment, but with all stakeholders that are involved or affected by our business activity. |
|
| Quality System | |
|
We ensure that the highest quality and safety standards are implemented in the management of our products.
The Quality Management System of INTEGRIS Pharma supports the company’s processes for the import, distribution and sale of Pharmaceutical Products and the import, storage, distribution and sale of Medical Devices. The QMS meets the requirements of ISO 9001:2015, and is primarily focused on customer satisfaction and on the continuous improvement of processes, so us to ensure that we consistently provide products and services that meet customer and applicable statutory and regulatory requirements.. |
|
We value the power of our team and nurture the talent of our people. We work agilely and foster innovation, creativity and efficiency.
Read More